Most popular stories on GeekWire for the week of Dec. 28, 2025 – GeekWire

Most popular stories on GeekWire for the week of Dec. 28, 2025 – GeekWire


Get caught up on the latest technology and startup news from the past week. Here are the most popular stories on GeekWire for the week of Dec. 28, 2025.

Sign up to receive these updates every Sunday in your inbox by subscribing to our GeekWire Weekly email newsletter.

Most popular stories on GeekWire

Angelina “Angy” Smith, who has been chief financial officer at the company since April, assumed the leadership position earlier this month, becoming Rad’s fourth CEO in three years. … Read More

Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates. … Read More

Seattle-area venture capitalists polled by GeekWire say there are clear signs of excess in early-stage AI startups, but they largely reject the idea of a catastrophic bubble and argue the technology is already delivering real value. … Read More

Microsoft is pushing AI agents deep into Windows, reviving a platform strategy that once made the PC operating system dominant. … Read More

This week on the GeekWire Podcast: The FCC’s decision to add foreign-made drones to its national security “Covered List” could upend the U.S. … Read More

SmarTek21 has sued TGP GP Management, accusing the New York-based advisor of flawed due diligence in a $5.2 million acquisition that has since required repeated cash infusions. … Read More

Illustration: Orion engine firing during lunar flyby

In the coming year, NASA is due to send four astronauts around the moon, and Blue Origin will put a lander on the lunar surface. … Read More

Prime Video features a few versions of the film, including one that cuts out a key sequence in the life of protagonist George Bailey. … Read More

Our latest Startup Radar spotlights four early stage tech startups in the Seattle region: Amera, Clara, Oiyko, and Specbook. … Read More

Mitera Biosciences is emerging from stealth with a mission to develop new drugs for autoimmune diseases and organ transplant rejection. … Read More

Comments are closed, but trackbacks and pingbacks are open.